A detailed history of Corton Capital Inc. transactions in Alector, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 23,237 shares of ALEC stock, worth $114,093. This represents 0.05% of its overall portfolio holdings.

Number of Shares
23,237
Previous 79,878 70.91%
Holding current value
$114,093
Previous $362,000 70.17%
% of portfolio
0.05%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.34 - $6.58 $245,821 - $372,697
-56,641 Reduced 70.91%
23,237 $108,000
Q2 2024

Aug 14, 2024

BUY
$4.19 - $6.23 $334,688 - $497,639
79,878 New
79,878 $362,000
Q2 2022

Aug 15, 2022

SELL
$7.65 - $14.24 $121,428 - $226,031
-15,873 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$13.02 - $20.78 $305,462 - $487,519
-23,461 Reduced 59.65%
15,873 $226,000
Q4 2021

Feb 14, 2022

BUY
$19.35 - $25.54 $761,112 - $1 Million
39,334 New
39,334 $812,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $405M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.